We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+12.41%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$2.41B
AUM Growth
+$457M
(+23%)
Cap. Flow
+$309M
Cap. Flow
% of AUM
12.8%
Top 10 Holdings %
Top 10 Hldgs %
6.55%
Holding
3,413
New
1,082
Increased
689
Reduced
503
Closed
1,137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$16.5M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$16.2M |
| 3 |
NVIDIA
NVDA
|
+$15.8M |
| 4 |
Philip Morris
PM
|
+$15.3M |
| 5 |
Microsoft
MSFT
|
+$14.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$13.3M |
| 2 |
CRH
CRH
|
+$11.8M |
| 3 |
GE Aerospace
GE
|
+$11.8M |
| 4 |
Johnson & Johnson
JNJ
|
+$11M |
| 5 |
Vertiv
VRT
|
+$10.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.02% |
| 2 | Technology | 16.8% |
| 3 | Industrials | 12.48% |
| 4 | Consumer Discretionary | 11.54% |
| 5 | Healthcare | 10.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
ABVC BioPharma
ABVC
$27.6M
| $117K | ﹤0.01% |
52,625
-7,814
| -13% | -$10.6K |
|
1852
Codexis
CDXS
$161M
| $116K | ﹤0.01% |
+47,492
| New | +$111K |
|
1853
Standard BioTools
LAB
$311M
| $116K | ﹤0.01% |
96,491
-61,596
| -39% | -$68.3K |
|
1854
Smith & Wesson
SWBI
$657M
| $115K | ﹤0.01% |
13,283
-27,558
| -67% | -$261K |
|
|
TMQ
1855
Trilogy Metals
TMQ
$517M
| $115K | ﹤0.01% |
+85,352
| New | +$120K |
|
1856
Xeris Biopharma Holdings
XERS
$1.42B
| $115K | ﹤0.01% |
24,662
-191,566
| -89% | -$878K |
|
|
NHS
1857
Neuberger High Yield Strategies Fund Inc
NHS
$251M
| $113K | ﹤0.01% |
+14,968
| New | +$112K |
|
|
HTBK
1858
DELISTED
Heritage Commerce
HTBK
| $113K | ﹤0.01% |
+11,365
| New | +$104K |
|
|
SY
1859
So-Young International
SY
$197M
| $113K | ﹤0.01% |
+36,306
| New | +$35.7K |
|
|
FIRY
1860
Firy Inc
FIRY
$154M
| $112K | ﹤0.01% |
+16,492
| New | +$91.6K |
|
1861
Tilray
TLRY
$498M
| $112K | ﹤0.01% |
+27,097
| New | +$123K |
|
1862
Opko Health
OPK
$1.23B
| $112K | ﹤0.01% |
84,907
-224,383
| -73% | -$307K |
|
1863
Syndax Pharmaceuticals
SNDX
$1.74B
| $112K | ﹤0.01% |
11,959
-51,767
| -81% | -$570K |
|
|
LIEN
1864
Chicago Atlantic BDC
LIEN
$215M
| $112K | ﹤0.01% |
+10,776
| New | +$111K |
|
|
BWG
1865
BrandywineGLOBAL Global Income Opportunities Fund
BWG
$129M
| $111K | ﹤0.01% |
+13,340
| New | +$107K |
|
|
TERN
1866
DELISTED
Terns Pharmaceuticals
TERN
| $110K | ﹤0.01% |
+29,515
| New | +$92.2K |
|
1867
Protalix BioTherapeutics
PLX
$188M
| $109K | ﹤0.01% |
73,675
+31,849
| +76% | +$65.2K |
|
|
DENN
1868
DELISTED
Denny's
DENN
| $109K | ﹤0.01% |
26,589
-14,174
| -35% | -$54.4K |
|
1869
HF Foods Group
HFFG
$84M
| $108K | ﹤0.01% |
+33,874
| New | +$129K |
|
1870
Diamondrock Hospitality Co
DRH
$2.67B
| $108K | ﹤0.01% |
+14,044
| New | +$105K |
|
1871
Ranpak Holdings
PACK
$550M
| $108K | ﹤0.01% |
+30,133
| New | +$112K |
|
1872
Organon & Co
OGN
$3.55B
| $107K | ﹤0.01% |
+11,094
| New | +$114K |
|
1873
Kyverna Therapeutics
KYTX
$455M
| $107K | ﹤0.01% |
+34,939
| New | +$86.4K |
|
1874
Methode Electronics
MEI
$525M
| $107K | ﹤0.01% |
+11,206
| New | +$82.3K |
|
1875
Fastly Inc
FSLY
$3.26B
| $106K | ﹤0.01% |
+14,973
| New | +$100K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q2 2025 Portfolio in Review
As of Q2 2025, XTX Topco held 3,413 positions worth $2.41B, up 23% from $1.95B the previous quarter. Its ten largest holdings account for 6.5% of the portfolio.
XTX Topco deployed $309M of net new capital in Q2 2025, opening 1,082 new positions and adding to 689 existing holdings. Its largest new stake was Amazon: 83,425 shares worth $18.3M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Netflix, an estimated $13.3M trimmed.
- XTX Topco's largest Q2 2025 buy was Amazon: 83,425 shares worth $18.3M.
- XTX Topco added most to NVIDIA in Q2 2025, an estimated $15.8M increase.
- XTX Topco's biggest Q2 2025 reduction was Netflix, cutting an estimated $13.3M.
- XTX Topco fully exited CRH in Q2 2025, selling an estimated $11.8M.
- XTX Topco's ten largest holdings make up 6.5% of its $2.41B portfolio in Q2 2025.
- XTX Topco opened 1,082 new positions and closed 1,137 in Q2 2025.
- XTX Topco's portfolio value rose 23% quarter-over-quarter to $2.41B.
Based on XTX Topco's 13F filing for Q2 2025, filed 12 Aug 2025.